Pharmaceutical Excipient Market by Type, Formulation, Function, End-User

List of Tables

The Pharmaceutical Excipient Market was valued at USD 8.62 billion in 2023, expected to reach USD 9.22 billion in 2024, and is projected to grow at a CAGR of 7.62%, to USD 14.42 billion by 2030.

Pharmaceutical excipients are inactive substances formulated alongside the active pharmaceutical ingredient (API) of a medication, serving critical roles in promoting stability, bioavailability, and delivery of the drug. They are essential in various drug formulations, offering functionalities such as binding, coating, solubilizing, and preserving. Excipients are utilized across several applications, including oral, topical, parenteral, and inhalation preparations, with key end-use sectors comprising hospitals, clinics, and research institutions. The growth of the pharmaceutical excipient market is primarily driven by the expanding pharmaceutical sector, increased drug approvals, and significant advancements in drug delivery systems. Additionally, the rise in demand for oral medications and technologically advanced multifunctional excipients is opening avenues for market expansion. However, the market faces challenges, such as stringent regulatory guidelines and high costs associated with the development of new excipients, which can hinder growth. Limitations include potential risks of excipient-drug interactions and variability in excipient characteristics, impacting formulation consistency.

KEY MARKET STATISTICS
Base Year [2023]	USD 8.62 billion
Estimated Year [2024]	USD 9.22 billion
Forecast Year [2030]	USD 14.42 billion
CAGR (%)	7.62%

Among the latest opportunities are the rising focus on biopharmaceuticals and the growing implementation of personalized medicine, which necessitates novel excipient development to cater to unique delivery and stability needs. There's a continuous push towards natural and sustainable excipients due to growing environmental awareness, providing an excellent area for innovation. Exploring collaborations with biotech firms for excipient development in peptide and protein formulations can further drive growth. Research into co-processed and multifunctional excipients can also yield competitive advantages. The market is highly dynamic, characterized by rapid technological advancements and a robust pipeline of next-generation excipients. Businesses should strategically focus on R&D investments in innovative excipient types and formulations, leveraging collaborations to enhance capabilities and meet the diverse demands of modern drug formulations. Identifying niche markets with unmet excipient needs and tailoring solutions accordingly can secure a significant market position.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Excipient Market

The Pharmaceutical Excipient Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Rising incidence of cancer and other chronic and infectious diseases worldwide
- Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
- Significant emphasis on the production of multifunctional excipients
Market Restraints
- High cost associated with the production of advanced excipient
Market Opportunities
- Technological advancements in nanotechnology for excipients
- Ongoing research and development of excipients with numerous properties (Biobased)
Market Challenges
- Increasing regulatory stringency and issues regarding the compatibility of excipients

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Excipient Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Excipient Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Excipient Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Excipient Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Excipient Market

A detailed market share analysis in the Pharmaceutical Excipient Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Excipient Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Excipient Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Excipient Market

A strategic analysis of the Pharmaceutical Excipient Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Excipient Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Archer Daniels Midland Company, ARMOR PROTEINES S.A.S., Asahi Kasei Corporation, Ashland Inc., BASF SE, BIOGRUND GmbH, Chemische Fabrik Budenheim KG, Clariant AG, Colorcon Inc., Corel Pharma Chem Private Limited, Croda International Plc, Darling Ingredients, Inc., DFE Pharma GmbH & Co KG, DuPont de Nemours, Inc., Evonik Industries AG, Fuji Chemical Industries Co., Ltd., GATTEFOSSE SAS, Innophos Holdings, Inc., International Flavors & Fragrances Inc., JRS PHARMA GmbH + Co. KG, Kerry Group P.L.C., Lipoid GmbH, Lubrizol Corporation, L'AIR LIQUIDE S.A., Mallinckrodt plc, MEGGLE GmbH & Co. KG, Merck KGaA, Nagase & Co., Ltd., Nipon Soda Co., Ltd., NOF Corporation, Omya International AG, Peter Greven GmbH & Co. KG, R.T. Vanderbilt Holding Company, Inc., Roquette Freres S.A., Shin-Etsu Chemical Co., Ltd., Solvay S.A., SPI Pharma, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Excipient Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Type, market is studied across Inorganic and Organic. The Inorganic is further studied across Calcium Carbonate, Calcium Phosphate, Calcium Sulfate, Halites, and Metal Oxides. The Organic is further studied across Carbohydrates, Oleochemicals, Petrochemicals, and Proteins. The Carbohydrates is further studied across Cellulose, Starch, and Sugars. The Oleochemicals is further studied across Fatty Alcohols, Glycerin, and Mineral Stearates. The Petrochemicals is further studied across Acrylic Polymers, Glycols, Mineral Hydrocarbons, and Povidones. The Glycols is further studied across Butylene Glycol, Diethylene Glycol, Ethylene Glycol, Hexylene Glycol, Macrogol, Microglycol, and Propylene Glycol.
Based on Formulation, market is studied across Oral Formulations, Parenteral Formulations, and Topical Formulations. The Oral Formulations is further studied across Hard Gelatin Capsules, Liquid Formulations, Soft Gelatin Capsules, and Tablets.
Based on Function, market is studied across Binders, Coating Agents, Colorants, Disintegrants, Emulsifying Agents, Fillers & Diluents, Flavoring Agents & Sweeteners, Lubricants & Glidants, Preservatives, and Suspending & Viscosity Agents.
Based on End-User, market is studied across Biopharmaceutical Companies, Contract Manufacturing Organizations, Pharmaceutical Companies, and Research Laboratories.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-030EE48515E2

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising incidence of cancer and other chronic and infectious diseases worldwide
  - 5.1.1.2. Growth of the pharmaceuticals industry coupled with significant demand for generics & orphan drugs
  - 5.1.1.3. Significant emphasis on the production of multifunctional excipients
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with the production of advanced excipient
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements in nanotechnology for excipients
  - 5.1.3.2. Ongoing research and development of excipients with numerous properties (Biobased)
- 5.1.4. Challenges
  - 5.1.4.1. Increasing regulatory stringency and issues regarding the compatibility of excipients
5.2. Market Segmentation Analysis
- 5.2.1. Type: Potential demand and utilization of organic excipients
- 5.2.2. Formulation: Significant demand for oral formulations owing to its convenient drug delivery
- 5.2.3. Function: Coating agents provide physical and chemical protection for the drug
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Pharmaceutical Excipient Market, by Type

6.1. Introduction
6.2. Inorganic
- 6.2.1. Calcium Carbonate
- 6.2.2. Calcium Phosphate
- 6.2.3. Calcium Sulfate
- 6.2.4. Halites
- 6.2.5. Metal Oxides
6.3. Organic
- 6.3.1. Carbohydrates
  - 6.3.1.1. Cellulose
  - 6.3.1.2. Starch
  - 6.3.1.3. Sugars
- 6.3.2. Oleochemicals
  - 6.3.2.1. Fatty Alcohols
  - 6.3.2.2. Glycerin
  - 6.3.2.3. Mineral Stearates
- 6.3.3. Petrochemicals
  - 6.3.3.1. Acrylic Polymers
  - 6.3.3.2. Glycols
  - 6.3.3.2.1. Butylene Glycol
  - 6.3.3.2.2. Diethylene Glycol
  - 6.3.3.2.3. Ethylene Glycol
  - 6.3.3.2.4. Hexylene Glycol
  - 6.3.3.2.5. Macrogol
  - 6.3.3.2.6. Microglycol
  - 6.3.3.2.7. Propylene Glycol
  - 6.3.3.3. Mineral Hydrocarbons
  - 6.3.3.4. Povidones
- 6.3.4. Proteins

7. Pharmaceutical Excipient Market, by Formulation

7.1. Introduction
7.2. Oral Formulations
- 7.2.1. Hard Gelatin Capsules
- 7.2.2. Liquid Formulations
- 7.2.3. Soft Gelatin Capsules
- 7.2.4. Tablets
7.3. Parenteral Formulations
7.4. Topical Formulations

8. Pharmaceutical Excipient Market, by Function

8.1. Introduction
8.2. Binders
8.3. Coating Agents
8.4. Colorants
8.5. Disintegrants
8.6. Emulsifying Agents
8.7. Fillers & Diluents
8.8. Flavoring Agents & Sweeteners
8.9. Lubricants & Glidants
8.10. Preservatives
8.11. Suspending & Viscosity Agents

9. Pharmaceutical Excipient Market, by End-User

9.1. Introduction
9.2. Biopharmaceutical Companies
9.3. Contract Manufacturing Organizations
9.4. Pharmaceutical Companies
9.5. Research Laboratories

10. Americas Pharmaceutical Excipient Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pharmaceutical Excipient Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Pharmaceutical Excipient Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
- 13.3.1. Evonik's new spray drying facility enhances global supply and sustainability of oral excipients
- 13.3.2. Roquette's strategic acquisition of IFF Pharma Solutions to bolster global influence in drug delivery solutions and excipients market
- 13.3.3. Asahi Kasei enhances pharmaceutical safety with low-nitrite Ceolus MCC excipient and expanded production
- 13.3.4. Roquette Introduces New Advancement in Moisture Protection
- 13.3.5. Clariant Launches New Range Of Excipients To Improve Stability And Solubility of Apis at CPHI Barcelona
- 13.3.6. BASF, IFF Partner on Virtual Pharma Assistant Platform ZoomLab
- 13.3.7. Lubrizol Licenses Award-Winning Apisolex Excipient to Welton Pharma to Develop a Novel Cancer Therapeutic
- 13.3.8. Ingredion Announces Strategic Investments Expanding Into High-Value Pharmaceutical Ingredients
- 13.3.9. DFE Pharma Expands its Inhalation Portfolio with the Launch of Lactohale 400
- 13.3.10. Evonik invests USD 220 million in partnership with the U.S. Government to build a new lipid production facility for mRNA-based therapies in the U.S.
- 13.3.11. Lubrizol Launches Apisolex Technology
- 13.3.12. Univar Solutions Expands Pharmaceutical Products Portfolio Through New Distribution Agreement with Ashland
- 13.3.13. Azelis Strengthens Its Pharmaceutical Presence in India By Expanding its Partnership With Roquette
- 13.3.14. Roquette Expands Global Reach of Plant-Based Excipients Portfolio with Complete Acquisition of Crest Cellulose
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. ABITEC Corporation
2. Actylis
3. Archer Daniels Midland Company
4. ARMOR PROTEINES S.A.S.
5. Asahi Kasei Corporation
6. Ashland Inc.
7. BASF SE
8. BIOGRUND GmbH
9. Chemische Fabrik Budenheim KG
10. Clariant AG
11. Colorcon Inc.
12. Corel Pharma Chem Private Limited
13. Croda International Plc
14. Darling Ingredients, Inc.
15. DFE Pharma GmbH & Co KG
16. DuPont de Nemours, Inc.
17. Evonik Industries AG
18. Fuji Chemical Industries Co., Ltd.
19. GATTEFOSSE SAS
20. Innophos Holdings, Inc.
21. International Flavors & Fragrances Inc.
22. JRS PHARMA GmbH + Co. KG
23. Kerry Group P.L.C.
24. Lipoid GmbH
25. Lubrizol Corporation
26. L'AIR LIQUIDE S.A.
27. Mallinckrodt plc
28. MEGGLE GmbH & Co. KG
29. Merck KGaA
30. Nagase & Co., Ltd.
31. Nipon Soda Co., Ltd.
32. NOF Corporation
33. Omya International AG
34. Peter Greven GmbH & Co. KG
35. R.T. Vanderbilt Holding Company, Inc.
36. Roquette Freres S.A.
37. Shin-Etsu Chemical Co., Ltd.
38. Solvay S.A.
39. SPI Pharma, Inc.
40. Thermo Fisher Scientific Inc.